Bioxytran annual return on equity
2011
2012
2013
2017
2018
Bioxytran Return on Equity (ROE) Growth & History (BIXT)
Bioxytran's return on equity was −186.97% for fiscal 2018.
View full Bioxytran company overviewBioxytran annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2018 | 2018-12-31 | −186.97% | +65.92 pp |
| 2017 | 2017-12-31 | −252.89% | — |
| 2013 | 2013-12-31 | −828.16% | +58.40 pp |
| 2012 | 2012-12-31 | −886.56% | +7378.20 pp |
| 2011 | 2011-12-31 | −8,264.76% | — |
Bioxytran quarterly return on equity
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q1.14
Q2.14
Q4.17
Q1.18
Q2.18
Q3.18
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2018 | 2018-09-30 | −19.54% | — |
| Q2 2018 | 2018-06-30 | −22.07% | — |
| Q1 2018 | 2018-03-31 | −0.13% | — |
| Q4 2017 | 2017-12-31 | −87.53% | — |
| Q2 2014 | 2014-06-30 | −91.13% | — |
| Q1 2014 | 2014-03-31 | 58.76% | +544.63 pp |
| Q1 2013 | 2013-03-31 | −485.87% | −193.70 pp |
| Q4 2012 | 2012-12-31 | −280.90% | +1257.54 pp |
| Q3 2012 | 2012-09-30 | −301.20% | −104.06 pp |
| Q2 2012 | 2012-06-30 | −375.38% | −153.97 pp |
| Q1 2012 | 2012-03-31 | −292.17% | — |
| Q4 2011 | 2011-12-31 | −1,538.44% | — |
| Q3 2011 | 2011-09-30 | −197.14% | — |
| Q2 2011 | 2011-06-30 | −221.41% | — |
Bioxytran return on equity trends
Over the last five fiscal years, Bioxytran's return on equity increased from −828.16% to −186.97%, a change of +641.19 percentage points. The latest reported quarter, Q3 2018, shows −19.54%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bioxytran source filings ↗